Harshvardhan Maji

Successful rechallenge of bevacizumab after grade 4 bevacizumab induced hypertension in a case of carcinoma ovary, is rechallenging an option?-A Rare case report

A. Patel, H. Panchal, S. Parikh, 2022 .